ImmunoPrecise Antibodies Ltd. filed their 6-K report on May 1, 2023, detailing financial figures for the quarter ending April 30, 2023. The filing includes updates on accumulated depreciation and amortization, reflecting substantial asset movements and values as of specified dates.